Emmaus Life Sciences, Inc. EMMA
0.02 USD 0.00 (-16.00%)
At closeNov 10, 2026, 4:00 PM EST
0.012 Day range 0.012
0.008 52-week range 0.0879
- YTD
- +61.54%
- 1 year
- +85.84%
News
businesswire.com Emmaus Life Sciences Announces Agreement for Evaluation of L-glutamine for Pancreatic Cancer TORRANCE, Calif.--(BUSINESS WIRE)--Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced that it…
businesswire.com Emmaus Life Sciences Reports Quarterly Financial Results TORRANCE, Calif.--(BUSINESS WIRE)--Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its…
gurufocus.com Emmaus Life Sciences Reports Quarterly Financial Results Emmaus Life Sciences, Inc. (OTCQB: EMMA),a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its
businesswire.com Emmaus Life Sciences Reports Quarterly Financial Results TORRANCE, Calif.--(BUSINESS WIRE)--Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its…
businesswire.com Emmaus Life Sciences Reports Annual Financial Results TORRANCE, Calif.--(BUSINESS WIRE)--Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its…
businesswire.com Emmaus Life Sciences Announces Strategic Transaction TORRANCE, Calif.--(BUSINESS WIRE)--Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced that it…
prnewswire.com Emmaus Life Sciences Reports Quarterly Financial Results TORRANCE, Calif. , Nov. 14, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today…
prnewswire.com Emmaus Life Sciences Reports Quarterly Financial Results TORRANCE, Calif. , Aug. 14, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today…
prnewswire.com Emmaus Life Sciences Receives FDA Approval for Endari® Label Enhancements Changes Based on Additional Pharmacokinetics Data TORRANCE, Calif. , June 26, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today…
prnewswire.com Emmaus Life Sciences Reports Quarterly Financial Results TORRANCE, Calif. , May 15, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. ( OTCQB : EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today…
prnewswire.com Emmaus Life Sciences Reports Improved Quarterly Financial Results TORRANCE, Calif. , Nov. 19, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. ( OTCQB : EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today…
benzinga.com ProMIS Neurosciences And 2 Other Stocks Under $5 Executives Are Buying 
prnewswire.com Emmaus Life Sciences Reports Quarterly Financial Results TORRANCE, Calif. , Sept. 10, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC Markets: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease,…
prnewswire.com Emmaus Life Sciences Announces Willis C. Lee as Chief Executive Officer TORRANCE, Calif. , July 23, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCMarkets: EMMA), a leader in sickle cell disease treatment, announced that Willis C.
prnewswire.com Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program TORRANCE, Calif. , July 12, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCPK: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today…
prnewswire.com Emmaus Life Sciences Reports 2023 Financial Results TORRANCE, Calif. , July 3, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCPK: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today…
prnewswire.com Emmaus Life Sciences Reports Delayed Filing of Annual Report TORRANCE, Calif. , April 15, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, reported…
proactiveinvestors.com Emmaus Life Sciences obtains marketing authorization for sickle cell disease teatment in Puerto Rico Emmaus Life Sciences Inc (OTCQX:EMMA) said it had obtained marketing authorization from the Puerto Rico Department of Health for its sickle cell disease (SCD) treatment, Endari, an L-glutamine oral…
prnewswire.com Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico TORRANCE, Calif. , Feb. 2, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease (SCD) treatment, today announced that it has received marketing authorization…
proactiveinvestors.com Emmaus Life Sciences sees increased Endari sales in MENA and US during 3Q Emmaus Life Sciences Inc (OTCQX:EMMA) reported a year-over-year increase in third quarter revenue driven by increased sales of its sickle cell therapy Endari in the Middle East North Africa (MENA)…
prnewswire.com Emmaus Life Sciences Reports Q3 2023 Financial Results TORRANCE, Calif. , Nov. 14, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today…
benzinga.com 4 Penny Stocks Insiders Are Buying When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their…
benzinga.com Stocks That Hit 52-Week Lows On Monday 
benzinga.com Stocks That Hit 52-Week Lows On Friday 
benzinga.com Stocks That Hit 52-Week Lows On Thursday 
benzinga.com Stocks That Hit 52-Week Lows On Wednesday 
benzinga.com Stocks That Hit 52-Week Lows On Monday - benzinga.com Stocks That Hit 52-Week Lows On Friday
benzinga.com Stocks That Hit 52-Week Lows On Wednesday - benzinga.com Stocks That Hit 52-Week Lows On Tuesday
- benzinga.com Stocks That Hit 52-Week Lows On Friday
benzinga.com Stocks That Hit 52-Week Lows On Thursday - benzinga.com Stocks That Hit 52-Week Lows On Wednesday
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday
benzinga.com Stocks That Hit 52-Week Lows On Tuesday - benzinga.com 70 Biggest Movers From Yesterday
- benzinga.com 51 Stocks Moving In Thursday's Mid-Day Session
- benzinga.com 64 Biggest Movers From Yesterday
- benzinga.com 46 Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday
- benzinga.com 76 Biggest Movers From Yesterday
- benzinga.com 54 Stocks Moving In Monday's Mid-Day Session